HEALTH● LOWAug 27 · Aug 27, 2026, 6:33 AM
AbbVie files for EMA approval of Skyrizi for Crohn’s disease treatment
Seeking Alpha Tech
AbbVie has submitted an application to the European Medicines Agency for approval of Skyrizi as a treatment for Crohn's disease. This step is part of the regulatory process for new pharmaceutical products.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH22m agoBharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapyThe HinduHEALTH27m agoNigeria confirms first Ebola case is Bundibugyo strainVanguard NigeriaHEALTH28m agoNigeria reports first Ebola case in a decadebunburymail.com.au · AustraliaHEALTH28m agoMark Cuban 5 - step plan to make healthcare affordable targets contractual terrorism fortune.com · United States